According to our (Global Info Research) latest study, the global Hydrochlorothiazide API market size was valued at US$ 57.43 million in 2025 and is forecast to a readjusted size of US$ 84.14 million by 2032 with a CAGR of 5.6% during review period.
Hydrochlorothiazide API is a classic thiazide diuretic small molecule API that exerts diuretic and antihypertensive effects by inhibiting the Na ⁺ - Cl ⁻ co transporter in the renal distal tubules, increasing the excretion of sodium and water. It is widely used in the treatment of primary hypertension, edema, heart failure, and other diseases, and is often used as a basic component of compound antihypertensive drugs . In 2025, global Hydrochlorothiazide API production reached approximately 2,537 MT, with an average global market price of around US$ 22 per kg.The annual production capacity of hydrochlorothiazide API is 4,000 tons, with a gross profit margin of 20%.
Upstream: Benzothiazide precursors; Chlorosulfonation reagents (such as chlorosulfonic acid); Thiourea and ammonia reagents; Organic solvents (methanol, DMF, etc.).
Downstream applications: unilateral hydrochlorothiazide tablets (diuretic/antihypertensive); Compound antihypertensive drugs: valsartan+hydrochlorothiazide, losartan+hydrochlorothiazide, valsartan+hydrochlorothiazide.
Raw material costs account for 40% -60%; Manufacturing cost accounts for 20% -30%; Quality control and compliance account for 5% -10%; Environmental protection and waste treatment account for 5% -15%; Logistics and packaging account for 2% -5%.
Hydrochlorothiazide is a typical mature generic drug bulk active pharmaceutical ingredient (API), with expired patents, fully competitive global supply, transparent prices, and long-term low maintenance. The market demand has obvious rigidity and stability, mainly driven by the global population of hypertension patients and the use of compound antihypertensive drugs. The industrial structure is based on China and India as the core supply bases, and cost competition is the core logic of the industry, rather than technological barriers or innovation driven. Overall, this product belongs to the category of basic pharmaceutical raw materials with "low unit price, high volume, and low volatility", playing a stable bottom support role in the global cardiovascular drug supply chain.
This report is a detailed and comprehensive analysis for global Hydrochlorothiazide API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hydrochlorothiazide API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Hydrochlorothiazide API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Hydrochlorothiazide API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Hydrochlorothiazide API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hydrochlorothiazide API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hydrochlorothiazide API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Octavius Pharma, Cambrex, CTX Lifesciences, Manus Aktteva Biopharma, Anant Pharmaceuticals, Zhuhai Rundu Pharmaceutical, Suzhou Lixin Pharmaceutical, Shanghai Jindi Jiuzhou, Zhejiang Huahai Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hydrochlorothiazide API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity<99%
Purity≥99%
Market segment by Specification
USP Grade
EP Grade
CP Grade
Market segment by Application
Edematous Diseases
Hypertension
Major players covered
Octavius Pharma
Cambrex
CTX Lifesciences
Manus Aktteva Biopharma
Anant Pharmaceuticals
Zhuhai Rundu Pharmaceutical
Suzhou Lixin Pharmaceutical
Shanghai Jindi Jiuzhou
Zhejiang Huahai Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hydrochlorothiazide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hydrochlorothiazide API, with price, sales quantity, revenue, and global market share of Hydrochlorothiazide API from 2021 to 2026.
Chapter 3, the Hydrochlorothiazide API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hydrochlorothiazide API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hydrochlorothiazide API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hydrochlorothiazide API.
Chapter 14 and 15, to describe Hydrochlorothiazide API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Hydrochlorothiazide API. Industry analysis & Market Report on Hydrochlorothiazide API is a syndicated market report, published as Global Hydrochlorothiazide API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Hydrochlorothiazide API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.